Skip Navigation
CIBMTR Logo Sharing knowledge. Sharing Hope.

  • Print
  • Share

Immunobiology Working Committee Studies

The Immunobiology Working Committee provides scientific oversight for studies related to histocompatibility and other genetic and immunologic issues related to hematopoietic cell transplantation (HCT).

Learn more about the studies conducted through the Immunobiology Working Committee using the links below.

Studies In Progress

NumberTitleStatus
R02-40s/R03-63s Choosing donors with favorable KIR B genotypes for unrelated hematopoietic cell transplantation (HCT) results in superior relapse protection and better relapse-free survival for patients with acute myeloid leukemia (AML). Ongoing

Abstract(s)
Publication(s)
R03-70s Candidate gene study to examine the impact of chemokine and chemokine receptor gene polymorphisms on the incidence and severity of acute and chronic GVHD. Published
R04-98s Detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated stem cell transplantation (HCT) and their relationship to graft/patient outcome. Published
IB06-03 One antigen mismatch related donor vs. HLA-matched unrelated donor hematopoietic transplantation (HCT) in patients with acute leukemia: results in the era of molecular typing. Submitted
IB06-06 Comparison of transplant outcomes using HLA -identical siblings, single antigen mismatched related donors, phenotypically matched related donors or HLA -A, -B, -C and -DRB1 matched unrelated donors for treatment of malignant disease in children. Submitted
IB07-02 The effect of HLA mismatches at the amino acid level on hematopoietic stem cell transplantation (HCT). Submitted
IB05-03s Genetic polymorphisms in the genes encoding human IL-7 Receptor-a: Prognostic significance in allogeneic stem cell transplantation (HCT). Manuscript Preparation
IB06-02 Impact of mismatches in low expression HLA loci on the outcome of unrelated donor transplantation (HCT). Manuscript Preparation
IB06-04 Effect of age on outcome in patients undergoing related HLA mismatched/haploidentical stem cell transplantation (HCT). Manuscript Preparation

Abstract(s)
IB06-05 Use of high-resolution HLA data from the National Marrow Donor Program for the International Histocompatibility Working Group (IHWG) in hematopoietic cell transplantation (HCT). Manuscript Preparation
IB06-09s Detection of HLA antibody to the mismatched antigen in single antigen HLA-mismatched unrelated donor transplantation (HCT): Is it associated with GVHD outcome? Manuscript Preparation
IB07-01 Evaluation of HLA matching requirements for peripheral blood stem cells (PBSC) in unrelated hematopoietic stem cell transplantation (HCT). Manuscript Preparation
IB07-06 Human leukocyte antigen: DP epitope study. Manuscript Preparation
IB07-07 HLA -DR15 and hematopoietic stem cell transplantation (HCT) outcome. Manuscript Preparation
IB07-09 To develop and test a prognostic index for survival in chronic myelogenous leukemia matched unrelated donor cohorts. Manuscript Preparation
R03-65s Detection of H-Y antibodies in healthy female donors: Does H-Y presensitization predict male hematopoietic stem cell transplantation (HCT) outcome. Manuscript Preparation
R04-74s Functional significance of Killer-IG-ligand genes in HLA-matched and mismatched unrelated hematopoietic cell transplantation (HCT). Manuscript Preparation

Publication(s)
R04-75s Functional significance of cytokine gene polymorphisms in modulating risk of post-transplant complications. Manuscript Preparation
R04-76s Identification of functional single nucleotide polymorphisms (SNPs) in unrelated hematopoietic cell transplantation (HCT). Manuscript Preparation
IB05-02s Effect of single Class I mismatching on unrelated donor hematopoietic stem cell transplantation (HCT). Analysis
IB07-04 Employing advanced bioinformatic methods for predicting peptide specificities of HLA molecules in the characterization of permissible mismatches in hematopoietic cell transplantation (HCT). Analysis
IB07-05 Impact of donor-recipient ethnicity on risk of acute GVHD (GVHD) among HLA -A, B, C, DRB1, DQB1, DPB1 matched unrelated donor transplants. Analysis

Abstract(s)
IB07-08s Single nucleotide polymorphisms in the P53 Pathway (P53, MDM2, ATM AND P21/WAF1) and transplant outcome after unrelated haematopoietic stem cell transplantation (HCT). Analysis

Planned Studies

NumberTitleStatus
IB09-02s Non-permissive HLA-DPB1 disparities based on T-cell alloreactivity. Data File Preparation
GV04-01 Outcomes of Non-Identical Twin Transplants for Leukemia. Protocol Development
IB06-10 Evaluation of the impact of exposure to non-inherited maternal antigens (NIMA) during fetal life and breast feeding and to the inherited paternal antigens during pregnancy on the clinical outcome of hematopoietic cell transplantation (HCT) from haploidentical family members. Protocol Development
IB06-11s Effect of non-inherited maternal antigens (NIMA) in cord blood transplantation. Protocol Development
IB06-13 HLA Disparity Among Unrelated Umbilical Cord Blood Transplants Protocol Development
IB07-03 Analysis of KIR ligands in reduced intensity conditioning allogeneic hematopoietic stem cell transplantation (HCT). Protocol Development
IB08-02 HLA matching for unrelated hematopoietic cell transplantation (HCT) for non-malignant disorders. Protocol Development
IB08-04 Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation (HCT) in children. Protocol Development
IB08-05/LK08-04 Lymphotoxin alpha alleles in acute myelogenous leukemia (AML) relapse. Protocol Development
IB08-06 KIR ligands in umbilical cord blood hematopoietic cell transplantation (HCT). Protocol Development
IB08-08 Genome-wide association in unrelated donor hematopoietic cell transplant (HCT) recipients and donors. Protocol Development
IB09-01s Clinical importance of major histocompatibility complex haplotypes in umbilical cord blood transplantation. Protocol Development
IB09-03s Clinical relevance of cytokine/immune response genes in umbilical cord blood transplant. Protocol Development
IB09-04s

Donor/recipient gene polymorphisms of drug metabolism and in innate immune response post allele-matched unrelated donor hematopoietic stem cell transplantation (HCT).

Protocol Development
IB09-05s Identification of functional single nucleotide polymorphisms (SNPs) in umbilical cord blood transplant. Protocol Development
IB09-06s/RT09-04* Genetic polymorphisms and hematopoietic stem cell transplantation (HCT)-related mortality. Protocol Development
IB09-07s Clinical significance of genome-wide variation in unrelated donor hematopoietic stem cell transplantation (HCT). Protocol Development
IB09-08 Donor/recipient birth order in matched sibling hematopoietic stem cell transplantation (HCT). Protocol Development
R04-80s Impact of HLA matching on outcome in pediatric patients undergoing unrelated umbilical cord blood transplantation. Protocol Development

Recently Published Studies

NumberTitleStatus
IB05-01s Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Published

Publication(s)
IB06-07s Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease (IBD)-associated markers on GVHD or other outcomes in T-replete, unrelated donor transplantation (HCT). Published

Publication(s)
IB06-08 Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation. Published

Publication(s)
R01-60 HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Published

Publication(s)
R03-57s TNF, LTA and TGFB1 genotype distributions among acute graft versus host disease (aGVHD) subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study. Published

Publication(s)


Last updated: 06.4.2010